Sign inJoin waitlistJoin the waitlist

Oussama Wazni

Physician · Cleveland Clinic

Credentials: · · · ·

History

Cleveland Clinic
Present

Cleveland Clinic
2002–2004
Cardiovascular Disease
University of Texas Health Science Center at Houston
2001–2002
Cleveland Clinic
1998–2001
American University of Beirut
1997–1998
Case Western Reserve University School of Medicine
American University of Beirut Faculty of Medicine
1993–1997
American University of Beirut
1989–1993

Research

2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction
Review · Heart Rhythm · 2017 · Last of 29 authors · 1,004 citations
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial
JAMA · 2005 · First of 19 authors · 886 citations
Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart…
Heart Rhythm · 2009 · 881 citations

Walid Saliba
223 papers
Ayman Hussein
162 papers · 29 as a resident
Mohamed Kanj
159 papers · 17 as a fellow
Bryan Baranowski
103 papers · 4 as a fellow
Mandeep Bhargava
99 papers · 10 as a fellow
David Martin
94 papers
Pasquale Santangeli
80 papers
Thomas Callahan
80 papers · 2 as a fellow
AN
Andrea Natale
74 papers
KT
Khaldoun Tarakji
74 papers · 2 as a fellow
Mina Chung
62 papers
Arwa Younis
59 papers · 58 as a fellow

Clinical trials

Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
Principal investigator · Active not recruiting
Boston Scientific Corporation
2023–2028
Intracardiac Echocardiography Guided Watchman Device Implant
Principal investigator · Recruiting
The Cleveland Clinic
2022–2027
Assessment of CCM in HF With Higher Ejection Fraction
Principal investigator · Recruiting
Impulse Dynamics
2022–2029
Boston Scientific's Single Shot LUMINIZE RF Balloon Catheter in the Treatment of Symptomatic, Drug Refractory Paroxysmal Atrial Fibrillation
Principal investigator · Withdrawn
Boston Scientific Corporation
2021–2022